68ga-fapi-04
Small moleculeexperimentalImaging agent
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2020 (NCT04533828)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05999227 | N/A | Jun 20, 2023 | Huazhong University of Science and Technology |
| NCT05867589 | N/A | May 1, 2023 | Nanjing Medical University |
| NCT04831034 | Early Phase 1 (Phase 1) | Apr 1, 2021 | Fujian Medical University |
| NCT05003427 | Early Phase 1 (Phase 1) | Apr 1, 2021 | Chinese Academy of Medical Sciences |
| NCT04533828 | Early Phase 1 (Phase 1) | Sep 1, 2020 | Fujian Medical University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fujian Medical University | Academic/Hospital | 2 | 2 | 1 | 2020 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Nanjing Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
4 organizations
Page 1 / 1